AtriCure, Inc. announced that full year 2023 revenue is projected to be $394 million to $396 million, reflecting growth of approximately 19% to 20% over full year 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.12 USD | +1.05% | +6.91% | -38.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.02% | 1.06B | |
-4.98% | 181B | |
+2.84% | 112B | |
-2.68% | 67.92B | |
+4.53% | 50.1B | |
+8.00% | 44.27B | |
+9.39% | 40.41B | |
+25.30% | 31.95B | |
-0.17% | 25.82B | |
+17.27% | 25.29B |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- AtriCure, Inc. Provides Revenue Guidance for the 2023